Corcept Therapeutics | CORT - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Alaunos Therapeutics USD 613K 230K 2025-12
ANI Pharmaceuticals USD 62.58M 7.21M 2025-12
Ardelyx USD 28.2M 8.96M 2026-03
Assertio Holdings USD 14.66M 3.81M 2025-09
Aurora Cannabis CAD 68.03M 18.68M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Canopy Growth CAD 19.96M 1.83M 2025-12
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Esperion Therapeutics USD 65.07M 12.44M 2025-12
J&J USD 10.46B 1.53B 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Lexicon Pharmaceuticals USD 3.08M 714K 2025-12
Merck USD 4.4B 257M 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.46B 99M 2025-12
Novartis USD 4.46B 99M 2025-12
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 14.01M 1.14M 2026-03
Pfizer USD 5.02B 142M 2025-09
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09